Twitter LinkedIn
    Thursday, March 23
    Login
    0 Shopping Cart
    Twitter LinkedIn
    Private Equity InsiderPrivate Equity Insider
    • About Us
    • Digital Events
    • Our Network
      • Reach
      • Sponsors
      • Members
    Private Equity InsiderPrivate Equity Insider
    Home»Deals & Transactions»Lauxera Capital Partners invests in Caresyntax
    Deals & Transactions

    Lauxera Capital Partners invests in Caresyntax

    April 30, 20212 Mins Read
    LinkedIn Facebook Twitter Email WhatsApp
    Share
    LinkedIn Facebook Twitter Email WhatsApp

    Lauxera Capital Partners has made an investment in Caresyntax as part of a USD100 million Series C fundraise. Other new investors include PFM Health Sciences LP, Optum Ventures, Intel Capital, Vesalius Biocapital Partners, Arno Capital, and Reyazat Investments. 

    Caresyntax operates the leading, AI-driven, enterprise-grade platform for collecting, tracking, and analysing data on surgical procedures to enhance outcomes and patient safety. Through an innovative partnership strategy combined with direct focus on customer success, Caresyntax grew new contract value 250 per cent year-over-year in 2020. The company’s solutions are present in over 4,000 operating rooms (OR’s) today, adding four surgeries per minute to an increasingly compelling dataset already in the single-digit millions of procedures.

    Caresyntax was founded in and maintains its primary R&D and operations hub in Berlin, but also has a significant presence in the United States. In Europe, the company has developed a particularly strong footprint in France and Germany. The University Hospital of Strasbourg is a leading customer, using the Caresyntax platform to enrich orthopaedic training, improve surgeon scores, and track patient risk. Caresyntax has also expanded rapidly into the US anchored by the acquisition of Syus – an OR operations and cost analytics solution – in late-2019 and collaborations with leading institutions like University of Iowa Health Care and University of Massachusetts Medical School.

    Read more at Private Equity Wire

    Related

    Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.

    Investments
    Share. LinkedIn Facebook Twitter Email WhatsApp

    Related Posts

    Thyssenkrupp shares move higher on report of CVC interest in steel unit

    March 21, 2023

    BlackRock Not Working on Rival Bid for Credit Suisse

    March 18, 2023

    University of California invests $4 bn in redemption-stricken REIT

    January 3, 2023

    Warburg Pincus acquires K2 Insurance Services from Lee Equity Partners

    December 6, 2022

    Comments are closed.

    Other Articles

    QTS Realty Trust Stockholders Approve Acquisition by Blackstone Funds

    August 27, 2021

    LaSalle Asia Opportunity VI raises over $2.2B

    September 8, 2022

    Kohlberg & Company Acquires DecoPac from Snow Phipps Group, LLC

    May 23, 2021

    KKR acquires New Zealand’s Ritchies Transport

    August 27, 2021

    Private Equity Insider LLC
    1212 Avenue of the Americas
    New York City 10036
    USA

    [email protected]

    Twitter LinkedIn
    © 2023 Private Equity Insider LLC. All rights reserved.
    • About
    • Terms of Use
    • Cookie Policy
    • Privacy Policy
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.

    View Cart Checkout Continue Shopping

    Sign In or Register

    Welcome Back!

    Login to your account below.


    Lost password?